Lisandra Ravanelli Pessa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Lisandra Ravanelli Pessa has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Rafael da Rosa
Aché Laboratórios Farmacêuticos, Guarulhos, Brazil
3 shared publications - Romulo Dragani Reis
Aché Laboratórios Farmacêuticos, Guarulhos, Brazil
3 shared publications - Gabrielly Galdino Conrado
Instituto Euvaldo Lodi, São Paulo, Brazil
2 shared publications - Cristiano Ruch Werneck Guimarães
Aché Laboratórios Farmacêuticos, Guarulhos, São Paulo, Brazil
1 shared publication
Latest Publications
- Open Access
- 3 June 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (4) , 882
Correction to: Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
- 3 June 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (4) , 882
Open AccessCorrection to: Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
- Open Access
- 5 April 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (4) , 706-721
Building Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Natural products represent an important source of new leads in drug discovery research. Several drugs currently used as therapeutic agents have been developed from natural sources, bioactive crude extracts and their plant secondary metabolites being specifically important. The screening of natural products can provide greater structural diversity than standard synthetic chemistry and offer significant opportunities for finding novel low molecular weight lead compounds. However, research with natural products also presents challenges for drug discovery, such as access and use of biological resources, technical barriers to screening, isolation, characterization, and resupply. Therefore, different strategies are presented as possible for a natural product-based drug discovery process. This review leads the reader through the main processes necessary to develop a modern natural product-based drug discovery program by summarizing the methods and strategies used to assemble and manage natural product libraries of plant origin. In addition, it brings insightful comments from a pharmaceutical industry perspective and presents original content, such as a curation of commercially available natural product libraries. Graphical Abstract
- 5 April 2024
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 34 (4) , 706-721
Open AccessBuilding Natural Product–Based Libraries for Drug Discovery: Challenges and Opportunities from a Brazilian Pharmaceutical Industry Perspective
Natural products represent an important source of new leads in drug discovery research. Several drugs currently used as therapeutic agents have been developed from natural sources, bioactive crude extracts and their plant secondary metabolites being specifically important. The screening of natural products can provide greater structural diversity than standard synthetic chemistry and offer significant opportunities for finding novel low molecular weight lead compounds. However, research with natural products also presents challenges for drug discovery, such as access and use of biological resources, technical barriers to screening, isolation, characterization, and resupply. Therefore, different strategies are presented as possible for a natural product-based drug discovery process. This review leads the reader through the main processes necessary to develop a modern natural product-based drug discovery program by summarizing the methods and strategies used to assemble and manage natural product libraries of plant origin. In addition, it brings insightful comments from a pharmaceutical industry perspective and presents original content, such as a curation of commercially available natural product libraries. Graphical Abstract
- Open Access
- 19 July 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (12) , 3445-3458
Nonclinical evaluation of a Vitis vinifera extract towards a novel antiaging cosmetic ingredient
Background: Skin aging is regulated by multiple physiological processes, such as oxidative stress. Natural products have been considered as a promising source of antioxidant compounds. As a result, few innovative products on the market based on natural products tackle additional underlying mechanisms of skin aging.Aims: The present work reports the nonclinical evaluation of a novel extract from the skin of V. vinifera fruits (codified as ACH37 extract), with the aim of supporting its use as an antiaging cosmetic ingredient candidate in clinical trials.Methods: We employed enzymatic, phenotypic, and gene expression assays, both in vitro and ex vivo, to investigate the action of the ACH37 extract in different biological processes that could be related to skin aging mechanisms.Results: The ACH37 extract was able to scavenge reactive oxygen species (DPPH, O2−), prevent inflammation (LPS‐ and UV‐induced COX‐2, IL‐1β, and IL‐8 expression), modulate extracellular matrix remodeling (inhibiting elastase, MMP‐1, MMP‐3, and MMP‐12, as well as associated expression), increase telomere length, telomerase activity, and reverse the UV‐induced suppression of genes involved in skin protection. In addition, the ACH37 extract permeated human skin explants and presented antioxidant efficacy ex vivo.Conclusion: The results indicated that the ACH37 extract acts on multiple targets commonly related to skin aging, being a promising antiaging active ingredient candidate to be further investigated in clinical trials.
- 19 July 2023
- Published by Wiley in Journal of Cosmetic Dermatology
- Vol. 22 (12) , 3445-3458
Open AccessNonclinical evaluation of a Vitis vinifera extract towards a novel antiaging cosmetic ingredient
Background: Skin aging is regulated by multiple physiological processes, such as oxidative stress. Natural products have been considered as a promising source of antioxidant compounds. As a result, few innovative products on the market based on natural products tackle additional underlying mechanisms of skin aging.Aims: The present work reports the nonclinical evaluation of a novel extract from the skin of V. vinifera fruits (codified as ACH37 extract), with the aim of supporting its use as an antiaging cosmetic ingredient candidate in clinical trials.Methods: We employed enzymatic, phenotypic, and gene expression assays, both in vitro and ex vivo, to investigate the action of the ACH37 extract in different biological processes that could be related to skin aging mechanisms.Results: The ACH37 extract was able to scavenge reactive oxygen species (DPPH, O2−), prevent inflammation (LPS‐ and UV‐induced COX‐2, IL‐1β, and IL‐8 expression), modulate extracellular matrix remodeling (inhibiting elastase, MMP‐1, MMP‐3, and MMP‐12, as well as associated expression), increase telomere length, telomerase activity, and reverse the UV‐induced suppression of genes involved in skin protection. In addition, the ACH37 extract permeated human skin explants and presented antioxidant efficacy ex vivo.Conclusion: The results indicated that the ACH37 extract acts on multiple targets commonly related to skin aging, being a promising antiaging active ingredient candidate to be further investigated in clinical trials.